As AHR and ER exhibit “cross-talk” through a number of mechanisms, with a resultant impact on breast cancer cells (45–47), it is not surprising that human trials have examined chemoprevention of breast cancer (7, 8, 48). This evidence concerns the gene ESR1 and breast cancer.